Drugmaker Elder Pharmaceuticals is exploring options to sell its nutrition products business, two sources with direct knowledge of the development said. One of the sources said Elder is looking for a valuation of roughly $60-75 million for the business, which includes about 20 brands, and that discussions are at a very early stage.